Leukemia, Lymphocytic, Chronic, B-Cell
Concept
Vocabulary Service
Overview
subject area of
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch Academic Article
-
Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia Academic Article
-
Abnormalities in T-cell associated rearrangement of T-cell receptor gamma chain genes in B-cell chronic lymphocytic leukemia Academic Article
-
An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia Academic Article
-
Angiomatosis of skin with local intravascular immunoglobulin deposits, associated with monoclonal gammopathy. A potential cutaneous marker for B-chronic lymphocytic leukemia. Academic Article
-
Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia Academic Article
-
Central Nervous System Involvement with Chronic Lymphocytic Leukemia Academic Article
-
DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance Academic Article
-
Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies. Academic Article
-
Generation ofin vitroB-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate Academic Article
-
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells Academic Article
-
INDEPENDENT CLONAL ORIGIN OF COEXISTING CHRONIC LYMPHOCYTIC LEUKAEMIA AND MULTIPLE MYELOMA Academic Article
-
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study Academic Article
-
Increased DNA Synthesis and Repair-Enzyme Expression in Lymphocytes From Patients With Chronic Lymphocytic Leukemia Resistant to Nitrogen Mustards Academic Article
-
Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells Academic Article
-
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial Academic Article
-
Leukemia Cutis Presenting with Fingertip Hypertrophy Academic Article
-
Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia Academic Article
-
Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia Academic Article
-
Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance Academic Article
-
Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. Academic Article
-
Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-β-d-arabinofuranosylcytosine Academic Article
-
Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells Academic Article
-
Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline Academic Article
-
Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma Academic Article
-
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial* Academic Article
-
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial Academic Article
-
Telomerase activity in normal leukocytes and in hematologic malignancies Academic Article
-
The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group Academic Article
-
Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment Academic Article
-
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma Academic Article